Nasdaq bid price deficiency notice for Novonix (OTC: NVNXF) disclosed

Rhea-AI Filing Summary

Novonix Limited has filed a Form 6-K as a foreign private issuer for March 2026. The filing primarily furnishes an ASX announcement titled “Nasdaq Notice of Minimum Bid Price Deficiency” dated March 18, 2026, indicating the company is addressing a Nasdaq minimum bid price compliance matter.

Positive

• None.

Negative

• Nasdaq minimum bid price deficiency notice disclosed via attached ASX announcement, indicating an exchange compliance issue that could affect the company’s Nasdaq listing if not resolved within required timeframes.

Insights

Cross‑listing and compliance analyst

Novonix flags a Nasdaq minimum bid price deficiency notice, raising listing-compliance risk.

Novonix Limited reports an ASX announcement concerning a “Nasdaq Notice of Minimum Bid Price Deficiency.” Such notices typically signal that a company has fallen below exchange pricing standards and must follow a remediation timeline defined by the exchange’s rules.

The disclosure matters because continued non-compliance can ultimately threaten a Nasdaq listing if not cured within the allowed period. However, this excerpt does not detail the specific threshold, grace period, or planned remedies, so the scale and timing of any impact are not described here.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2026

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		ASX Announcement (NASDAQ Notice of Minimum Bid Price Deficiency) dated March 18, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:		/s/ Robert Long
		Robert Long
		Chief Financial Officer

Date: March 18, 2026

FAQ

What did Novonix Limited (NVNXF) report in its March 2026 Form 6-K?

Novonix Limited’s March 2026 Form 6-K furnishes an ASX announcement titled “Nasdaq Notice of Minimum Bid Price Deficiency” dated March 18, 2026. The report formally notifies investors of a Nasdaq minimum bid price compliance matter through the U.S. filing system.

What is the key issue highlighted for Novonix Limited (NVNXF) in this filing?

The key issue is a Nasdaq minimum bid price deficiency notice, referenced in an attached ASX announcement. This indicates a pricing-related compliance concern with Nasdaq’s listing standards, although this excerpt does not describe the detailed conditions, timelines, or specific consequences.

Which document is attached to Novonix Limited’s March 2026 Form 6-K?

The Form 6-K attaches Exhibit 99.1, an ASX announcement described as “Nasdaq Notice of Minimum Bid Price Deficiency” dated March 18, 2026. That announcement contains the substantive information about the Nasdaq compliance matter referenced in the report.

Who signed Novonix Limited’s March 2026 Form 6-K and in what capacity?

The Form 6-K was signed by Robert Long, who is identified as the company’s Chief Financial Officer. His signature indicates that Novonix Limited has duly authorized the submission of this report under the Securities Exchange Act of 1934.

Does Novonix Limited (NVNXF) report financial results in this March 2026 Form 6-K?

The March 2026 Form 6-K does not present financial results in the excerpt provided. Instead, it focuses on furnishing an ASX announcement concerning a Nasdaq minimum bid price deficiency notice and the related cross-listing compliance matter.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 32.2 KB